Cartesian Therapeutics
RNAC
RNAC
81 hedge funds and large institutions have $174M invested in Cartesian Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+20
Holders Change %
+32.79%
% of All Funds
1.66%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
39
Increased
24
Reduced
11
Closed
19
Calls
$183K
Puts
$79K
Net Calls
+$104K
Net Calls Change
+$35K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$13.3M |
| 2 |
BlackRock
New York
|
+$9.27M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$8.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.15M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.91M |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$15.9M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$11.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.09M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.68M |
| 5 |
Millennium Management
New York
|
-$2.37M |
